This Investment Digest is summarizing key observations in the private equity and venture capital ecosystem of the rapidly evolving and exponentially growing Longevity industry. Here we have presented the information about key industry trends, more than 20000 longevity companies, 50 leading investors in this sector, and more than 300 longevity-focused publicly traded corporations, outlining major investment rounds and relevant R&D trends illustrating the industry traction and readiness of institutional investors (including top-tier financial institutions) to potentially acquire most successful AgeTech, Longevity Fintech, and Longevity Biomedicine startups